Special NoticePosted Sep 3, 2026·Responses due Sep 8, 2026

Notice of Intent for NIH/NCATS ChemAxon Licenses Renewal

Health and Human Services (all) · OFFICE OF THE ASSISTANT SECRETARY FOR ADMINISTRATION (ASA)

Stage
Early notice (sources sought, presolicitation or special notice)
NAICS
513210
Value
Not stated
Solicitation
PCA-OD-07793
Set-aside
No Set aside used
PSC
7A21
Place
Bethesda, MD, USA
Contact
Leah Hinson (leah.hinson@hhs.gov)
CSV Email

Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.

Where this opportunity stands

Every notice posted under solicitation PCA-OD-07793 in this department, oldest first.

Early notice
  • Sep 3, 2026
    Special Notice
    Open
  • Sep 3, 2026 · this notice
    Special Notice
  • Sep 3, 2026
    Special Notice
    Open
Solicitation
None posted
Award
Not yet. Too few past cases at this agency to estimate timing (0 found; 10 needed).

Next steps for this stage

Standard steps for the notice type; not advice about this buyer.

  • Answer the notice: this is when the requirement can still be shaped.
  • Contact the contracting officer named on the notice.
  • Check who won similar work; they are the likely bidders.

What the notice says

THIS IS A NOTICE OF INTENT TO AWARD A SOLE SOURCE CONTRACT, NOT A REQUEST FOR COMPETITIVE QUOTES. A REQUEST FOR QUOTE (RFQ) WILL NOT BE ISSUED AND QUOTES WILL NOT BE REQUESTED. The National Institute of Health on behalf of the National Center for Advancing Translational Sciences (NCATS) intends to award a firm fixed price sole source contract under the authority of FAR 12.102(a), only one source being available to meet the Government's needs, to: Chemaxon LLC 4 Radnor Corporate Center Suite 350 Radnor, PA 19087 NCATS hereby submits a notice of intent to award a sole source firm fixed price pur… (show all)

chase order for the renewal of the existing ChemAxon Software License Suite, including associated maintenance, upgrades, and technical support, for a twelve (12) month period of performance commencing within thirty (30) days of award. This is not a new requirement. NCATS has used the ChemAxon software suite since at least 2020 under a prior contract for which multiple option periods were exercised. Although that contract is now expired, the requirement remains current and ongoing. Continued access to the software is necessary to avoid interruption to established scientific and informatics workflows that support NCATS translational research and small-molecule discovery activities. The ChemAxon Software License Suite supports daily operations involving chemistry data management, chemical structure drawing, compound registration and evaluation, structure searching, standardization, property prediction, virtual synthesis, and related cheminformatics workflows. These capabilities enable NCATS to integrate chemistry information with biological and assay data in support of its mission to advance the development, testing, and implementation of diagnostics and therapeutics. The North American Industry Classification System (NAICS) code for this requirement is 513210 Software Publishers business size $47M. The period of performance will be for one (1) 12-month base period from date of award to September 10, 2026 � September 9, 2026. This notice of intent is not a request for competitive proposals, and no solicitation document exists for the requirement. This hereby constitutes a synopsis of the requirement. CLOSING STATEMENT The determination not to compete this proposed contract action is solely within the discretion of the Government. Information received will normally be considered for the purpose of determining whether to conduct a competitive procurement. The Government will not be responsible for any costs incurred by responding to this notice. This is NOT a request for quotes or proposals. Questions or comments to this Notice of Intent should be directed to the Primary Point of Contact Leah L. Hinson via e-mail only Leah.Hinson@hhs.gov (no phone calls/voice mail). Messages regarding questions will not be accepted and will not receive a response). Please indicate in the subject of your email: Notice of Intent Question Submission � PCA-OD�07793 ChemAxon Software License Suite Renewal. Contracting Office Address: Office of Mission Acquisition Solutions (OMAS) Office of Acquisitions (OA) | Assistant Secretary for Financial Resources (ASFR) U.S. Department of Health and Human Services Primary Point of Contact: Leah L. Hinson- Leah.Hinson@hhs.gov

Who won similar work

9 award notices on SAM.gov in the last 24 months. Match: Same agency (Health and Human Services (all)), same NAICS 513210.

WinnerAwardsValueLast
GARTNER, INC. · $IT1$9.2MSep 23, 2025
CARAHSOFT TECHNOLOGY CORP1$5.1MJul 30, 2025
Nationwide Pharmaceutical LLC1$678KMay 29, 2025
NETCOMM INC1$400KApr 2, 2025
NEW TECH SOLUTIONS, INC.1$195KSep 15, 2026
UNICOM SYSTEMS INC1$183KJan 20, 2026
Unique Technology Systems LLC1$122KFeb 17, 2026
FREIGHTTRAIN LLC1$92KMar 16, 2026
Revvity Signals Software, Inc.1$33KOct 6, 2026

Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in.

Latest awards

Competitive landscape

For the 8 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.

  • 0 of these past winners lobbied Health & Human Services, Dept of (HHS) since 2024 (0 filings)
  • 0 of their lobbyists list a past Health & Human Services, Dept of (HHS) job
  • No corporate PAC money from them to the overseeing committees since 2024
  • 0 foreign-agent (FARA) registrations
See who and the source records with Pro

Policy around it

Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.

  • 0 bills named on the past winners' lobbying filings
  • 252 rules from the department in the last 12 months
  • 0 executive orders naming the agency in the last 12 months
See who and the source records with Pro

Market

For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards.

  • 1 of the past winners are listed companies
  • 0 insider buys and 5 insider sells at them in the last 90 days
See who and the source records with Pro

Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.

Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.